Dongwha Pharm.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
May 15, 2023 at 03:11 am EDT
Share
Dongwha Pharm.Co.,Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 59.84 million compared to KRW 160.79 million a year ago. Net income was KRW 12,538.21 million compared to KRW 5,236.78 million a year ago.
Basic earnings per share from continuing operations was KRW 453 compared to KRW 189 a year ago. Basic earnings per share was KRW 453 compared to KRW 189 a year ago.
DONGWHA PHARM.CO., LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products consist of ethical drugs, including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies, and over-the-counter (OTC) drugs, including cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. It also provides medicine raw materials, health food and drinks, as well as cosmetics. The Company distributes its products within domestic market and to overseas markets.
DONGWHA PHARM.CO.,LTD 
